HELP
Cybin Inc. Common StockRecent alerts on HELP
All signals →
SEC filing
HELP Adds Langer, Brannan to SAB; Advances NSAs for Depression, Anxiety
39d ago
SEC filing
HELP CEO Transition: Michael Cola Steps Down, Eric So Resumes Interim CEO Role; APPROACH Trial Readout Q4
42d ago
News
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
43d ago
News
Psychedelic stocks rally after Trump orders faster PTSD research; Compass Pathways, Atai lead gains
43d ago
SEC filing
HELP Appoints Dr. Ken Kramer SVP Medical Affairs with 25Yr Neuroscience Experience, Former BMS Lead, Breakthrough Therapy Designation
47d ago
SEC filing
HELP Appoints Jill Conwell Chief People Officer, 20+ Years Pharma HR Experience, Supports Pipeline Growth
81d ago
SEC filing
HELP Reports $0 Revenue, $0 EPS, Phase 2 GAD Study Shows 10-Point HAM-A Improvement, 67% Responders, 39% Remission, 90-Minute Acute Effects, No Serious AEs
89d ago
SEC filing
HELP Reports No Material Events, No Updates to Financials or Operations
89d ago
SEC filing
HELP Publishes Nature Medicine Phase 2a SPL026 MDD Trial Results Showing -7.35 MADRS Reduction, 35% Response, 29% Remission, Phase 2 GAD Data Expected Q1 2026
104d ago
News
Cybin GAAP EPS of -$1.00 misses by $0.41
109d ago
SEC filing
HELP Reports $290M Assets, $101M Net Loss, ($3.40) EPS
109d ago
Get push alerts for HELP
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS